News and Trends 3 May 2017 French Biotech gets a Second Opportunity to Fight Liver Fibrosis …in the second quarter of 2017 and deliver results in 2018. Genkyotex specializes in NOX enzymes, a family of proteins that play a key role in several diseases. In particular,… May 3, 2017 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Best in Biotech 31 Oct 2023 Six biotech companies in Melbourne that have been making the news …is home to multinational companies like medtech company PolyNovo which develops polymers that treat wounds, and biopharma company Clinuvel, which specializes in metabolic and acute disorders. Other global companies like… October 31, 2023 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 4 Aug 2022 The biggest Asia-Pacific biotech investments in July 2022 …infectious diseases including seasonal influenza, pandemic influenza, rabies and coronavirus. China Immunotech came second with a $44 million Series B financing round to bankroll the development of cell therapies for… August 4, 2022 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 1 Jun 2017 Why Should we be Excited about the Emerging Microbiome Field? …to understand physiology. If you think about any metabolic pathway, it is clear that the microbiome has an impact, and there is a direct effect of drugs that needs to… June 1, 2017 - 4 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 15 Nov 2022 Fooditive takes world first bee-free honey a step closer …into a proprietary strain of yeast. Fooditive’s bio-identical honey When fed with nutrients and precision-fermented to replicate the metabolic processes that occur in the honeybee stomach, this yields a product… November 15, 2022 - 2 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
In Depth 5 May 2025 The biggest biotech funding rounds in April 2025 …phase 1/2 clinical trial for the treatment of the genetic disorder alpha-1 antitrypsin deficiency (AATD), and to develop a pipeline of novel RNA-editing medicines for cardiometabolic and other diseases. Private… May 5, 2025 - 4 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 21 Aug 2017 AstraZeneca Teams Up with German Biotech to Develop mRNA Therapy …based on mRNA with chemical modifications that overcome problems of instability and immunogenicity associated with these molecules. The company focuses on metabolic and respiratory disease, which has led it to… August 21, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Best in Biotech 12 Dec 2023 Five biotech companies based in Dubai you should know about …distributing innovative specialty biopharmaceuticals, ensuring these groundbreaking treatments reach patients in the MENA region. With a strategic focus on key therapeutic areas like immunology, oncology, neuroscience, metabolic, and rare diseases,… December 12, 2023 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 6 Aug 2020 €112M Fund Launched to Commercialize UCL’s Gene Therapy Research …disease areas as such,” Lane said. Examples of investments in the pipeline for this fund include a gene therapy for an undisclosed neurometabolic disorder, a gene therapy for epilepsy, and… August 6, 2020 - 2 minutesmins - By Antara Mazumdar Share WhatsApp Twitter Linkedin Email
Startup Scout 9 Mar 2018 This Portugese Biotech is Developing a Vaccine for Life-Threatening Multibacterial Infections …women. The antibodies target GAPDH, an a gene involved in basic metabolic functions. Comment: Being awarded a grant form the Bill and Melinda Gates foundation is no small feat. The… March 9, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 12 Dec 2016 Meet Photanol: Harnessing Cyanobacteria’s Powers for Green Chemicals …concepts, which yielded exciting research like this new carbon-fixing metabolic pathway. It was really great to talk to Gordon and see how these are being brought to the industry. Images:… December 12, 2016 - 3 minutesmins - By Denise Neves Gameiro Share WhatsApp Twitter Linkedin Email
News and Trends 1 Oct 2018 Update: Forbion’s Life Science Fund Tops Goal by €90M …in investing in biotech companies in the spaces of neurodegenerative diseases, inflammation, microbiome, cardiovascular and metabolic disease and fibrosis. 80% of the investment will be reserved for companies in the… October 1, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email